HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rao Muralikrishna Adibhatla Selected Research

Choline-Phosphate Cytidylyltransferase

3/2013Retraction: CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke.
3/2006CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke.
5/2004Cytidine-5'-diphosphocholine affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rao Muralikrishna Adibhatla Research Topics

Disease

16Stroke (Strokes)
03/2013 - 01/2002
9Brain Ischemia (Cerebral Ischemia)
02/2007 - 01/2002
4Wounds and Injuries (Trauma)
01/2010 - 08/2003
4Brain Injuries (Brain Injury)
06/2008 - 05/2006
4Infarction (Infarctions)
02/2007 - 10/2002
4Ischemia
05/2004 - 05/2002
4Transient Ischemic Attack
10/2003 - 01/2002
3Cerebral Infarction
04/2012 - 10/2005
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2010 - 03/2006
3Ischemic Stroke
01/2010 - 01/2008
3Schizophrenia (Dementia Praecox)
01/2008 - 05/2006
3Bipolar Disorder (Manic Depressive Psychosis)
01/2008 - 05/2006
3Nervous System Diseases (Neurological Disorders)
01/2008 - 05/2006
3Neurodegenerative Diseases (Neurodegenerative Disease)
05/2006 - 10/2002
2Retinoblastoma (Glioblastoma, Retinal)
06/2012 - 06/2010
2Hypoxia (Hypoxemia)
04/2012 - 06/2010
2Atherosclerosis
01/2010 - 01/2008
2Niemann-Pick Diseases (Niemann Pick Disease)
01/2008 - 05/2006
2Epilepsy (Aura)
01/2008 - 08/2007
2Inflammation (Inflammations)
01/2008 - 01/2008
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2008 - 08/2007
2Traumatic Brain Injuries (Traumatic Brain Injury)
08/2007 - 05/2002
1Neoplasms (Cancer)
04/2012
1Atherosclerotic Plaque (Atheroma)
04/2012
1Vascular Remodeling
06/2008
1Parkinson Disease (Parkinson's Disease)
01/2008
1Huntington Disease (Huntington's Disease)
01/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2008
1Alzheimer Disease (Alzheimer's Disease)
01/2008
1Type A Niemann-Pick Disease
01/2008
1Spinal Cord Injuries (Spinal Cord Injury)
08/2007
1Multiple Sclerosis
08/2007

Drug/Important Bio-Agent (IBA)

10Cytidine Diphosphate Choline (Citicoline)IBA
03/2013 - 01/2002
7Phosphatidylcholines (Phosphatidylcholine)IBA
03/2013 - 10/2002
5Phospholipases A2 (Phospholipase A2)IBA
03/2013 - 08/2003
5Proteins (Proteins, Gene)FDA Link
06/2010 - 08/2003
5LipidsIBA
01/2010 - 05/2006
4CeramidesIBA
06/2012 - 01/2008
4Phospholipases (Phospholipase)IBA
01/2008 - 01/2002
4Phospholipids (Phosphatides)FDA LinkGeneric
01/2008 - 08/2003
4SphingomyelinsIBA
01/2008 - 01/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 01/2005
3Choline-Phosphate CytidylyltransferaseIBA
03/2013 - 05/2004
3tricyclodecane-9-yl-xanthogenateIBA
06/2012 - 06/2010
3oxidized low density lipoproteinIBA
01/2010 - 01/2008
3CytokinesIBA
01/2008 - 02/2007
2phosphatidylcholine-specific phospholipase CIBA
04/2012 - 01/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2008 - 08/2003
2Secretory Phospholipases A2IBA
01/2008 - 02/2007
2EicosanoidsIBA
01/2008 - 01/2008
2Pharmaceutical PreparationsIBA
10/2005 - 01/2005
2salicylhydroxamic acid (SHAM)IBA
05/2004 - 08/2003
2hydroxide ionIBA
10/2003 - 08/2003
2Hydroxyl RadicalIBA
10/2003 - 08/2003
2Arachidonic Acid (Vitamin F)IBA
10/2003 - 10/2002
1Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2012
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
04/2012
1phosphatidylcholine-ceramide phosphocholine transferaseIBA
06/2010
1IronIBA
01/2010
1Serine Proteases (Serine Protease)IBA
06/2008
1disufenton sodium (NXY 059)IBA
06/2008
1Tissue Plasminogen Activator (Alteplase)FDA Link
06/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008
1Matrix Metalloproteinases (MMPs)IBA
06/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2008
1Interleukin-1 (Interleukin 1)IBA
01/2008
1Docosahexaenoic AcidsIBA
01/2008
1Eicosapentaenoic AcidIBA
01/2008
1CholesterolIBA
01/2008
1Carrier Proteins (Binding Protein)IBA
01/2008
1ApolipoproteinsIBA
01/2008
1Apolipoprotein B-100 (Apo B 100)IBA
01/2008
1Apolipoprotein E4IBA
01/2008
1EndocannabinoidsIBA
01/2008
1Interleukin-1alpha (Interleukin 1 alpha)IBA
02/2007
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2007
1Messenger RNA (mRNA)IBA
03/2006
1Liposomes (Liposome)IBA
10/2005
1XenobioticsIBA
01/2005
1Malondialdehyde (Propanedial)IBA
10/2003
1SalicylatesIBA
08/2003
12,3-dihydroxybenzoic acidIBA
08/2003
1Cardiolipins (Cardiolipin)IBA
10/2002
1Glutathione (Reduced Glutathione)IBA
10/2002
1SpermineIBA
05/2002
1SpermidineIBA
05/2002
1PolyaminesIBA
05/2002
1PutrescineIBA
05/2002

Therapy/Procedure

1Therapeutics
01/2008
1Ketogenic Diet
01/2008
1Intravenous Administration
10/2005
1Oral Administration
10/2005